http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1063939-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
filingDate 1976-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1979-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481d2e0200f92ea7b9c255ce4faebc47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ff0576b39a046448d529bc3978ccd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48a7d6947eb48b9f52cee431d0645dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d9a2e9033d5f76b83daa60de786b3f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5438d66728d315a132cf015ba308b48a
publicationDate 1979-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1063939-A
titleOfInvention Suppression of thrombocyte aggregation
abstract ABSTRACT OF THE DISCLOSURE 2-(4,5-bis-p-chlorophenyloxazol-2-yl-mercapto)-propionic acid and its physiologically acceptable salts in the form of an admixture with acetylsalicylic acid or a physiologically acceptable salt thereof is useful for suppressing aggregation of thrombocytes, particularly when administered in a mole ratio of the acetylsalicylic acid to the priopionic acid derivative of 60:1 to 0.1:1. This is useful especially in humans, e.g. for prophylaxis and therapy in cases involving risk of arterial or venous thrombosis.
priorityDate 1975-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453827953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86738180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3793118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410550660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426141981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426001747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3614769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453810375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8054309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3770554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86738752

Total number of triples: 45.